Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma

Clinical trial NCT00002909 · COMPLETED

Trial details

NCT number: NCT00002909
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1997-02-01
Primary completion: 2000-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.